Summary
The prevalence of an internal tandem duplication (ITD) of the juxtamembrane domain-coding sequence and a missense mutation of D835 within the kinase domain of the FLT3 gene is 15–35% and 5–10% of adults with acute myeloid leukemia (AML), respectively. In addition, point mutations, deletions, and insertions have been found in the juxtamembrane domain and in the other codons within the kinase domain, though these are less common. Several large-scale studies in well-documented patients published to date have demonstrated that FLT3 mutations are strongly associated with a poor prognosis and a high leukemia cell count in patients with AML, suggesting that FLT3 mutations are involved in disease progression. Because the detection of FLT3 mutations is fast, easy, and inexpensive, mutation analysis should be performed as a routine test. This chapter describes methods for detecting ITD and D835 mutations in the FLT3 gene.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gilliland D. G. and Griffin J. D. (2002) The roles of FLT3 in hematopoiesis and leukemia. Blood 100, 1532–1542.
Kiyoi H. and Naoe T. (2002) FLT3 in human hematologic malignancies. Leuk. Lymphoma 43, 1541–1547.
Stirewalt D. L. and Radich J. P. (2003) The role of FLT3 in haematopoietic malignancies. Nat. Rev. Cancer 3, 650–665.
Nakao M., Yokota S., Iwai T., et al. (1996) Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia 10, 1911–1918.
Yamamoto Y., Kiyoi H., Nakano Y., et al. (2001) Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood 97, 2434–2439.
Thiede C., Steudel C., Mohr B., et al. (2002) Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood 99, 4326–4335.
Spiekermann K., Bagrintseva K., Schoch C., Haferlach T., Hiddemann W., and Schnittger S. (2002) A new and recurrent activating length mutation in exon 20 of the FLT3 gene in acute myeloid leukemia. Blood 100, 3423–3425.
Piccaluga P. P., Bianchini M., and Martinelli G. (2003) Novel FLT3 point mutation in acute myeloid leukaemia. Lancet Oncol. 4, 604.
Stirewalt D. L., Meshinchi S., Kussick S. J., et al. (2004) Novel FLT3 point mutations within exon 14 found in patients with acute myeloid leukaemia. Br. J. Haematol. 124, 481–484.
Kiyoi H., Naoe T., Nakano Y., et al. (1999) Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood 93, 3074–3080.
Kottaridis P. D., Gale R. E., Frew M. E., et al. (2001) The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood 98, 1752–1759.
Kiyoi H., Towatari M., Yokota S., et al. (1998) Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product. Leukemia 12, 1333–1337.
Bianchini M., Ottaviani E., Grafone T., et al. (2003) Rapid detection of Flt3 mutations in acute myeloid leukemia patients by denaturing HPLC. Clin. Chem. 49, 1642–1650.
Taketani T., Taki T., Sugita K., et al. (2004) FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy. Blood 103, 1085–1088.
Stirewalt D. L., Kopecky K. J., Meshinchi S., et al. (2001) FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia. Blood 97, 3589–3595.
Whitman S. P., Archer K. J., Feng L., et al. (2001) Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. Cancer Res. 61, 7233–7239.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this protocol
Cite this protocol
Kiyoi, H., Naoe, T. (2006). FLT3 Mutations in Acute Myeloid Leukemia. In: Iland, H., Hertzberg, M., Marlton, P. (eds) Myeloid Leukemia. Methods In Molecular Medicine™, vol 125. Humana Press. https://doi.org/10.1385/1-59745-017-0:189
Download citation
DOI: https://doi.org/10.1385/1-59745-017-0:189
Publisher Name: Humana Press
Print ISBN: 978-1-58829-485-2
Online ISBN: 978-1-59745-017-1
eBook Packages: Springer Protocols